Sana Biotechnology Acquires Oscine Corp.
October 30, 2020
Sana Biotechnology announced the acquisition of Oscine Corp., integrating Oscine’s glial progenitor cell program and technologies into Sana’s broader platform to advance CNS therapies. Steve Goldman, Oscine’s scientific founder, joined Sana as Head of CNS Therapy; terms of the acquisition were not disclosed.
- Buyers
- Sana Biotechnology, Inc.
- Targets
- Oscine Corp.
- Industry
- Biotechnology
- Location
- New York, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.